Clinical Trial Update: Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery [Phase 2, Phase 3]

View source ↗

Summary

Astellas Pharma-sponsored Phase 2/Phase 3 trial assessing prevention of venous thromboembolism in patients undergoing elective total knee replacement has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Venous Thromboembolism | Phase 2, Phase 3 | Status: COMPLETED